Literature DB >> 19671450

Antibiotic effects on mitochondrial translation and in patients with mitochondrial translational defects.

Christie N Jones1, Chaya Miller, Ariel Tenenbaum, Linda L Spremulli, Ann Saada.   

Abstract

The infantile presentation of mitochondrial respiratory chain defects frequently simulates acute bacterial infection and sepsis. Consequently, broad spectrum antibiotic therapy is often initiated before definitive diagnosis is reached and without taking into consideration the potential harm of antibiotics affecting mitochondrial translation. Here, we demonstrate that some commonly used translation-targeted antibiotics adversely affect the growth of fibroblasts from patients with defective mitochondrial translation systems. In addition, we show that these antibiotics inhibit mitochondrial translation in vitro. Our results suggest that patients with mitochondrial translation defects may be more vulnerable to toxic-side-effects following the administration of certain translation-targeted antibiotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671450     DOI: 10.1016/j.mito.2009.08.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  23 in total

1.  Survival in critical illness is associated with early activation of mitochondrial biogenesis.

Authors:  Jane E Carré; Jean-Christophe Orban; Lorenza Re; Karen Felsmann; Wiebke Iffert; Michael Bauer; Hagir B Suliman; Claude A Piantadosi; Terry M Mayhew; Patrick Breen; Martin Stotz; Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

Review 2.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Combined OXPHOS complex I and IV defect, due to mutated complex I assembly factor C20ORF7.

Authors:  Ann Saada; Shimon Edvardson; Avraham Shaag; Wendy K Chung; Reeval Segel; Chaya Miller; Chaim Jalas; Orly Elpeleg
Journal:  J Inherit Metab Dis       Date:  2011-05-24       Impact factor: 4.982

4.  Structure of the yeast mitochondrial large ribosomal subunit.

Authors:  Alexey Amunts; Alan Brown; Xiao-Chen Bai; Jose L Llácer; Tanweer Hussain; Paul Emsley; Fei Long; Garib Murshudov; Sjors H W Scheres; V Ramakrishnan
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

Review 5.  Mitochondrial diseases: the contribution of organelle stress responses to pathology.

Authors:  Anu Suomalainen; Brendan J Battersby
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-09       Impact factor: 94.444

Review 6.  Elements of ribosomal drug resistance and specificity.

Authors:  Gregor M Blaha; Yury S Polikanov; Thomas A Steitz
Journal:  Curr Opin Struct Biol       Date:  2012-09-13       Impact factor: 6.809

7.  Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome.

Authors:  Andrey G Tereshchenkov; Malgorzata Dobosz-Bartoszek; Ilya A Osterman; James Marks; Vasilina A Sergeeva; Pavel Kasatsky; Ekaterina S Komarova; Andrey N Stavrianidi; Igor A Rodin; Andrey L Konevega; Petr V Sergiev; Natalia V Sumbatyan; Alexander S Mankin; Alexey A Bogdanov; Yury S Polikanov
Journal:  J Mol Biol       Date:  2018-02-02       Impact factor: 5.469

Review 8.  Approaches toward super-resolution fluorescence imaging of mitochondrial proteins using PALM.

Authors:  Timothy A Brown; Richard D Fetter; Ariana N Tkachuk; David A Clayton
Journal:  Methods       Date:  2010-01-12       Impact factor: 3.608

9.  Monitoring mammalian mitochondrial translation with MitoRiboSeq.

Authors:  Sophia Hsin-Jung Li; Michel Nofal; Lance R Parsons; Joshua D Rabinowitz; Zemer Gitai
Journal:  Nat Protoc       Date:  2021-05-05       Impact factor: 13.491

10.  Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound.

Authors:  Anna Golubitzky; Phyllis Dan; Sarah Weissman; Gabriela Link; Jakob D Wikstrom; Ann Saada
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.